CID arrests two PhD students in II PU paper leak case

Bengaluru, Apr 15: Karnataka government will explore Ayurveda for fighting the deadly COVID-19, Ayurveda practitioner Dr Giridhar Kaje said here on Wednesday.

After meeting the Chief Minister, Dr Kaje informed media that on a trial basis, ten Coronavirus patients will be administered Ayurvedic treatment in a designated hospital.

Chief Minister B S Yediyurappa has consulted senior doctors on the issue, he said.

Bengaluru, Jun 5: An earthquake of magnitude 4.0 on the Richter Scale jolted Karnataka on Friday morning while another with a magnitude of 4.7 was felt in Jharkhand.

The tremors were felt in Hampi (Karnataka) and Jamshedpur (Jharkhand), according to the National Center for Seismology (NCS).

According to NCS, the aftershocks were felt at 6:55 am in both the places today.

New Delhi, Jun 11: The Department of Pharmaceuticals has given its nod for lifting of ban on the export of hydroxychloroquine, Union Minister D V Sadananda Gowda said on Wednesday.

India had banned export of hydroxychloroquine on March 25, with some exceptions, amid views in some quarters that the drug could be used to fight COVID-19. On April 4, it completely banned the exports without any exception.

"Department of Pharmaceuticals has approved the lifting of ban on export of Hydroxychloroquine API as well as formulations. Manufacturers except SEZ/EOU Units have to supply 20 per cent production in the domestic market," the minister of chemicals and fertilisers said in a tweet.

The Directorate General of Foreign Trade (DGFT) has been asked to issue formal notification in this regard, he added.

In another tweet, Gowda said he held discussions with representatives of pharma companies along with some of his ministerial colleagues on the challenges being faced by the industry and on the roadmap to boost exports.

"Had detailed discussion with representatives of pharma companies & association, stakeholder Ministries along with Hon Ministers @piyushGoyal  ji, @HardeepSPuri  ji, & @MansukhMandviya  ji on entire gamut of challenges faced by the industry as well as strategies to boost pharma export," Gowda tweeted.

India exported hydroxychloroquine API (active pharmaceutical ingredient) worth USD 1.22 billion in April-January 2019-20.

During the same period, exports of formulations made from hydroxychloroquine was at USD 5.50 billion.